Both patients died shortly after initiation of cetuximab due to diffuse alveolar damage, suggesting that EGFR inhibitors should be used with extreme caution in lung transplant recipients.

• 提示我们对于肺移植的病人在应用EGFR拮抗剂，一定要非常小心谨慎。